Effect of Cilostazol compared with Clopidogrel about prevention of myocardial injury after elective percutaneous coronary intervention :Prospective,Randomized,Open,Blinded-Endpoint trial
- Conditions
- ischemic heart disease
- Registration Number
- JPRN-UMIN000002351
- Lead Sponsor
- Department of Cardiology, Nagoya University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Not provided
(1)Patients with unstable angina (2)Patients who use drug-eluting stents (DES) (3)Patients with a medical history of acute myocardial infarction within three months (4)Patients whose levels of CK and CK-MB,troponin-I are above upper limits of normal at the time of consent acquisition (5)Patients taking an anticoagulant (warfarin) (6)Patients who have a medical history of hypersensitivity to cilostazol, aspirin, and/or clopidogrel (7)Patients with thrombocytopenia (8)Patients with hepatic dysfunction (AST (GOT) or ALT(GPT) > 100 IU/L within three months) (9)Patients with renal dysfunction (serum creatinine >2.0mg/dl within three months) (10)Patients with congestive heart failure (11)Patients who are pregnant (12)Patients with bleeding
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method